Previous Article | Next Article 
Journal of Virology, September 2000, p. 8038-8047, Vol. 74, No. 17
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Membrane Interface-Interacting Sequences within the Ectodomain of
the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein: Putative
Role during Viral Fusion
Tatiana
Suárez,1
William R.
Gallaher,2
Aitziber
Agirre,1
Félix M.
Goñi,1 and
José L.
Nieva1,*
Unidad de Biofísica (CSIC-UPV/EHU)
and Departamento de Bioquímica, Universidad del País
Vasco, 48080 Bilbao, Spain,1 and
Department of Microbiology, Immunology and Parasitology,
Louisiana State University Health Sciences Center, New Orleans,
Louisiana 701122
Received 27 March 2000/Accepted 30 May 2000
 |
ABSTRACT |
We have identified a region within the ectodomain of the fusogenic
human immunodeficiency virus type 1 (HIV-1) gp41, different from the
fusion peptide, that interacts strongly with membranes. This conserved
sequence, which immediately precedes the transmembrane anchor, is not
highly hydrophobic according to the Kyte-Doolittle hydropathy
prediction algorithm, yet it shows a high tendency to partition into
the membrane interface, as revealed by the Wimley-White interfacial
hydrophobicity scale. We have investigated here the membrane effects
induced by NH2-DKWASLWNWFNITNWLWYIK-CONH2
(HIVc), the membrane interface-partitioning region at the C
terminus of the gp41 ectodomain, in comparison to those caused by
NH2-AVGIGALFLGFLGAAGSTMGARS-CONH2 (HIVn), the fusion peptide at the N terminus of the
subunit. Both HIVc and HIVn were seen to induce
membrane fusion and permeabilization, although lower doses of
HIVc were required for comparable effects to be detected.
Experiments in which equimolar mixtures of HIVc and
HIVn were used indicated that both peptides may act in a
cooperative way. Peptide-membrane and peptide-peptide interactions
underlying those effects were further confirmed by analyzing the
changes in fluorescence of peptide Trp residues. Replacement of the
first three Trp residues by Ala, known to render a defective gp41
phenotype unable to mediate both cell-cell fusion and virus entry, also abrogated the HIVc ability to induce membrane fusion or
form complexes with HIVn but not its ability to associate
with vesicles. Hydropathy analysis indicated that the presence of two
membrane-partitioning stretches separated by a collapsible intervening
sequence is a common structural motif among other viral envelope
proteins. Moreover, sequences with membrane surface-residing residues
preceding the transmembrane anchor appeared to be a common feature in
viral fusion proteins of several virus families. According to our
experimental results, such a feature might be related to their
fusogenic function.
 |
INTRODUCTION |
The human immunodeficiency virus
type 1 (HIV-1) relies on the fusogenic activity of the gp120/41
glycoprotein at the virion surface to enter and infect the
CD4+ host cells (7, 24). Activation of the HIV-1
envelope protein occurs after the binding of the surface gp120 subunit
to CD4 and human chemokine receptors (4, 7, 8, 24).
Subsequently, the transmembrane gp41 subunit supports structural
rearrangements involving a coiled-coil domain (5, 12, 25,
39) that bring about the eventual exposure to the aqueous medium
of the fusion peptide at its N terminus (12, 13, 24, 25).
The fusion peptide is likely to insert into the target lipid bilayer,
making gp41 capable of interacting simultaneously with the viral and cell membranes (5, 8, 12, 13, 25, 39). The involvement of
this conserved hydrophobic segment of about 25 amino acids in
triggering fusion is supported by prediction (13, 15, 40), mutational analysis (2, 10, 11, 35), and in vitro studies carried out using synthetic peptides and model membranes (16, 20,
23, 27-31, 36). Fusion peptides inserted into the target membrane might drive the aggregation of gp41 trimers at initial sites
of fusion as well (39). It has been argued that a
higher-order envelope glycoprotein complex is involved in HIV-1 fusion
as well as in analogous viral fusion processes (17, 19, 39).
Recent resolution of the atomic structure of the gp41 ectodomain
demonstrates that this region is organized into a very stable helical
bundle or "hairpin" (4, 5, 39). The core of this crystallized structure is constituted by a triple-stranded coiled coil.
Three
-helices oriented obliquely in an antiparallel sense pack
hydrophobically against the core coiled coil. The resulting trimeric
structure would locate both fusion peptides and transmembrane anchors
at the same end of the molecule. Two main models have been developed to
explain the involvement of the hairpin structure in the gp41-mediated
membrane fusion process. In one model (4, 5, 12, 25, 39, 43)
a transient intermediate exists between the native nonfusogenic and the
fusogenic six-helix complex, termed by Chan and Kim (4) as
the "prehairpin." The alternative model postulates that the hairpin
is already present in the prefusion state (38). Binding to
CD4 and chemokine receptors would expose the hairpin in close vicinity
to the target membrane. Both molecular models propose that this
structure represents the fusion-active version of gp41. Thus, formation
of a hairpin could be coupled to the apposition of the target cell and
viral membranes provided that gp41 trimers interacted simultaneously
with both membranes.
The hypothesis of the hairpin structure as a fusion mediator has gained
support from studies indicating that synthetic peptides corresponding
to helical regions in the gp41 core structure are inhibitors of HIV-1
fusion. The DP-178 synthetic peptide representing the hydrophobic
-helix that interacts with the coiled-coil core of the hairpin
completely inhibits virus-mediated cell-cell fusion and reduces
infectivity (43). DP-178-induced inhibition occurs after
receptor binding-induced activation and blocks the fusion process at a
hemifusion state (12, 25). This peptide (also called T-20)
has already been tested in clinical trials and has been shown to be an
effective suppressor of HIV-1 replication in infected individuals
(19a). In addition, based on the knowledge of this
functional structure new strategies for the development and
identification of new anti-HIV compounds have recently been delineated
(8a, 9a).
At this point it is unclear how hairpin-apposed membranes can fuse
(4). Several findings indicate that the fusion peptide inserted into the target membrane would cause the distortion of the
bilayer organization necessary for merging (6, 30).
Hydropathy-at-interface plots elaborated according to the
hydrophobicity scale developed by Wimley and White (33, 42,
45) identify, in addition to the fusion peptide, a second region
within the ectodomain of the fusogenic HIV-1 gp41 that shows high
tendency to partition into the membrane interface. This tryptophan-rich
region is located proximal to the viral membrane overlapping the DP-178
region at its C terminus and preceding the transmembrane anchor of
gp41. Recent mutational analysis has revealed its importance for
gp41-mediated fusion and infectivity. Salzwedel et al. (34)
identified several mutations indicating that this gp41 stretch is
dispensable for the normal maturation, transport, and receptor-binding
ability of the protein but required for membrane fusion. Later
functional characterization in cell-cell fusion assays by
Muñoz-Barroso et al. (26) revealed three different
phenotypes among the studied gp41 mutants: wild-type-like phenotypes
showing reduced activity, defective variants unable to mediate fusion,
and mutants able to assemble nonexpanding fusion pores.
Our results here demonstrate that, as for the N-terminal fusion
peptide, HIVc, a sequence representing the pretransmembrane region partitions into membranes and induces the same type of perturbations. Moreover, the fusion peptide stimulates the activity of
this second membrane-interacting sequence. These observations would be
consistent with the existence of concerted action by both sequences
that could simultaneously destabilize gp41-apposed membranes at the
points of fusion. A mutation shown to inhibit cell-cell fusion and
virus entry without affecting the maturation, transport, or CD4-binding
ability of HIV-1 glycoprotein (34) caused the abrogation of
both membrane fusion by the membrane-bound peptide and the ability to
form complexes with the N-terminal fusion peptide. This finding
provides a direct correlation between the activity of the
HIVc peptide in vitro and the activity of gp41 in the virus
and the transfected-cell context. Hydropathy analysis of several
X-ray-solved ectodomain structures further indicates that, following
the intervening protein sequences involved in the hairpin formation and
preceding the transmembrane anchor, an additional membrane-interacting
domain is also present. Sequence analysis extended to other viral
fusion proteins indicates that an unusual concentration of aromatic
residues, just preceding the transmembrane anchor, is commonly found
among several virus families including retroviruses, filoviruses,
orthomyxoviruses, rhabdoviruses, alphaviruses, and flaviviruses.
We propose that the existence of a membrane interface-residing sequence
close to the transmembrane domain can be a general motif for a
considerable number of viral fusion proteins and may be related to
their fusion activity. Our study of the gp41 pretransmembrane region
provides a mechanistic basis for understanding its role in viral fusion
and infection and might be important for devising new inhibitors based
on this sequence.
 |
MATERIALS AND METHODS |
Materials.
Dioleoylphosphatidylcholine (DOPC),
dioleoylphosphatidylethanolamine (DOPE), cholesterol (CHOL),
and the fluorescent probes N-(7-nitro-benz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine (N-NBD-PE) and N-(Lissamine-rhodamine
B-sulfonyl)phosphatidylethanolamine (N-Rh-PE) were purchased from
Avanti Polar Lipids (Birmingham, Ala.).
8-Aminonaphthalene-1,3,6-trisulfonic acid sodium salt (ANTS) and
p-xylenebis(pyridinium)bromide (DPX) were from Molecular
Probes (Junction City, Oreg.). Octaethyleneglycol monododecyl ether
(C12E8) and Triton X-100 were obtained from
Sigma (St. Louis, Mo.). All other reagents were of analytical grade.
The sequences
NH2-DKWASLWNWFNITNWLWYIK-CONH2 (HIVc),
DKAASLANAFNITNWLWYIK-CONH2
[HIVW(1-3)A], and
NH2-AVGIGALFLGFLGAAGSTMGARS-CONH2 (HIVn) were synthesized as their C-terminal
carboxamides and purified (estimated homogeneity, >90%) by Quality
Controlled Biochemicals, Inc. (Hopkinton, Mass.). Peptide stock
solutions were prepared in dimethyl sulfoxide (spectroscopy grade).
Vesicle preparation.
Large unilamellar vesicles (LUV)
consisting of DOPC, DOPE, and CHOL (molar ratio, 1:1:1) were prepared
according to the extrusion method of Hope et al. (18) in 5 mM HEPES-100 mM NaCl (pH 7.4). Lipid concentrations of liposome
suspensions were determined by phosphate analysis (3). The
mean diameter of DOPC-DOPE-CHOL vesicles was 130 nm as estimated by
quasielastic light scattering using a Malvern Zeta-Sizer instrument.
Fluorimetric assays for vesicle destabilization.
All
fluorescence measurements were conducted in thermostatically controlled
cuvettes (37°C) using a Perkin-Elmer LS50-B spectrofluorimeter. The
medium in the cuvettes was continuously stirred to allow the rapid
mixing of peptide and vesicles.
Membrane lipid mixing was monitored using the resonance energy transfer
(RET) assay described by Struck et al. (37). The assay is
based on the dilution of N-NBD-PE and N-Rh-PE. Dilution due to membrane
mixing results in an increase in N-NBD-PE fluorescence. Vesicles
containing 0.6 mol% of each probe were mixed with unlabeled vesicles
at a 1:4 ratio (final lipid concentration, 0.1 mM). The 7-nitro-benz-2-oxa-1,3-diazol-4-yl NBD emission at 530 nm was monitored, with the excitation wavelength set at 465 nm. A cutoff filter at 515 nm was used between the sample and the emission monochromator to avoid scattering interferences. The fluorescence scale
was calibrated such that the zero level corresponded to the initial
residual fluorescence of the labeled vesicles and the 100% value
corresponded to complete mixing of all the lipids in the system. The
latter value was set by the fluorescence intensity of vesicles labeled
with 0.12 mol% of each fluorophore at the same total lipid
concentration as in the fusion assay.
Release of vesicular contents to the medium was monitored by the
ANTS-DPX assay. LUV containing 12.5 mM ANTS, 45 mM DPX, 20
mM NaCl, and
5 mM HEPES (
9) were obtained by separating the
unencapsulated material by gel filtration in a Sephadex G-75 column
eluted with 5 mM HEPES-100 mM NaCl (pH 7.4). Osmolarities were
adjusted to 200 mosM in a cryoscopic osmometer (Osmomat 030; Gonotec,
Berlin, Germany). Fluorescence measurements were performed by
setting
the ANTS emission at 520 nm and the excitation at 355
nm. A cutoff
filter (470 nm) was placed between the sample and
the emission
monochromator. The 0% leakage corresponded to the
fluorescence of the
vesicles at time zero; 100% leakage was the
fluorescence value
obtained after the addition of Triton X-100
(0.5% [vol/vol]).
Peptide-membrane and peptide-peptide interactions.
Peptide-vesicle and peptide-peptide interactions were investigated by
monitoring the change in emitted Trp fluorescence. In order to produce
an intrinsically fluorescent sequence, Phe8 was replaced by Trp within
the HIVn peptide. Control experiments demonstrated that the
resulting fluorescent analog was equally active at inducing membrane
destabilization (data not shown). The peptide-vesicle mixtures were
incubated for 10 min at 37°C and then for 1 h at room
temperature before data acquisition. Corrected spectra were recorded in
a Perkin-Elmer MPF-66 spectrofluorimeter with excitation set at 280 nm
and slits of 2.5 nm (excitation) and 10 nm (emission). The signal was
further corrected for inner-filter effects.
Peptide partitioning into DOPC-DOPE-CHOL LUV was estimated by
physically separating unbound and bound peptides. Unbound peptides
were
removed from the mixtures by gel filtration in a Sephadex
G-75 column.
Vesicles (1 ml; 1 mM total lipid) were incubated
at 37°C for 15 min
with peptides prior to gel filtration. Chromatographed
peptide-lipid
samples containing bound peptides were subsequently
solubilized with 2 mM C
12E
8 in order to minimize the scattering
contribution to Trp fluorescence. The Trp signal at 333 nm (excitation
at 280 nm) was normalized to the amount of coeluted lipid that
was
simultaneously quantified also by means of spectrofluorimetry.
To that
end, we used liposomes labeled with 0.1 mol% of N-NBD-PE
and N-Rh-PE.
In addition to lipid quantification, NBD and rhodamine
fluorescence
measurements confirmed complete vesicle solubilization
by
C
12E
8. With [
L] and
[
W] as the molar concentrations of peptides
in lipid and
water, respectively, the apparent mole fraction partition
coefficient
was estimated as described previously (
41,
42)
using the
following expression:
Kapp = {([
PT 
[
PF])/[
L]}/([
PF]/[
W])
where
[
PT] is the molar concentration of peptide
added to samples
before chromatography and
[
PF] is the peptide concentration in
aqueous
solution after incubation with vesicles. The latter can
be determined
from
where
F0 and
F represent Trp
fluorescence emission intensities in the peptide-vesicle mixtures
before and after chromatography,
respectively.
 |
RESULTS |
A classical way of detecting amino acid stretches bearing
hydrophobic character in proteins is to plot their so-called average hydropathies (21, 42). As shown in Fig.
1, for gp41 ectodomains in primate
lentiviruses, such a plot based on the widely used hydropathy scale of
Kyte and Doolittle (21) clearly identified two conspicuous
areas on the hydrophobic side above the zero midpoint line. The
N-terminal hydrophobic regions consisted of the fusion peptides,
whereas the regions at the C terminus represented the transmembrane
anchors.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 1.
Hydropathy plots corresponding to sequences spanning the
ectodomains of several Env transmembrane (TM) subunits of primate
lentiviruses (top, HIV-1, BH10 isolate, residues 500 to 720 of the Env
precursor; middle, HIV-2, SBLISY isolate, residues 490 to 710 of the
Env precursor; bottom, simian immunodeficiency virus (SIV), Mm142-83
isolate, residues 510 to 730 of the Env precursor). The stretches
plotted include the fusion peptide and the TM anchor regions.
Hydropathy plots (mean values for a window of 11 amino acids) were
elaborated using the Kyte-Doolittle (KD) hydropathy index
(21) (thin lines) and Wimley-White (WW) interfacial
hydrophobicity (45) (thick lines) scales for individual
residues.
|
|
The hydropathy index for each amino acid adopted by Kyte and Doolittle
(21) was an estimate based on bulk phase partitioning of
side chain hydrophobicity alone. As recently proposed by White and
Wimley (42), other contributions, specifically those arising from the peptide bonds and the bilayer effect, must be taken into account in order to compose a hydrophobicity scale that could be useful
to detect membrane-interacting amino acid sequences. Thus, these
authors elaborated a whole-residue scale based on the water-to-membrane
interface transfer free energies for each amino acid (45).
This "interface scale" was determined for
1-palmitoyl-2-oleoylphosphatidylcholine bilayer interfaces using two
types of oligopeptides, which allowed the evaluation of both side chain
and peptide bond hydrophobicities.
When average interfacial hydrophobicity was plotted for gp41
ectodomains of primate lentiviruses, two main hydrophobic regions were
also detected (Fig. 1). The region at the N terminus was coincident
with that detected by the Kyte-Doolittle hydropathy plot, meaning that
the interfacial hydrophobicity plot identified the fusion peptide as
well. However, at the C terminus a clear segregation between the
hydrophobic region detected by the Kyte-Doolittle plot and that
detected by Wimley-White interfacial hydrophobicity occurred. The
latter was shifted closer to the N terminus. This finding is further
illustrated by the data displayed in Table 1. For the three analyzed lentiviruses,
the positions of the hydropathy-positive peaks at the gp41 N terminus
coincided in both types of plots, the only difference being that the
hydrophobic regions detected by the Kyte-Doolittle plot were somewhat
wider. In contrast, the positive maxima detected by Wimley-White within the ectodomain C-terminal region were shifted 15 to 20 residues toward
the N terminus.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Positions and lengths of hydrophobic regions within
ectodomains of envelope transmembrane subunits of primate
lentiviruses as detected by
hydropathy analysisa
|
|
The position of the hydrophobic region at the C terminus in the
Kyte-Doolittle plot (residues 681 to 707 in HIV-1) is almost coincident
with that of the putative transmembrane segment of gp41 (residues 684 to 706 in HIV-1). We conclude that, at the C terminus of the gp41
ectodomain, there exists a wide nonpolar region (approximately 40 residues long) which is segmented into two domains: one located
somewhat farther from the protein C terminus (residues 664 to 683 in
HIV-1) showing high propensity to reside within the membrane interface
and another one closer to the C terminus, which constitutes the
membrane-spanning anchor. The hydrophobic-at-interface region (residues
664 to 683) detected within the C terminus of the gp41 ectodomain does
not merely reflect the common preferential localization of aromatic
residues within the interfacial boundary regions that precede
transmembrane segments (22, 32). Both the peak range and the
intensity of the hydrophobic maximum indicate that, for this fusogenic
viral subunit, the stretch of membrane surface-residing amino acids
that precedes the transmembrane domain is uniquely elongated (compare
Tables 1 and 3 and see Discussion below).
Figure 1 identifies a second membrane-partitioning domain within the
gp41 ectodomain (residues 664 to 683) in addition to the fusion peptide
(residues 512 to 534). Since the whole-residue interfacial
hydrophobicity scale was composed on the basis of the partitioning into
zwitterionic membrane interfaces (42, 45), we characterized
the membrane-interacting capabilities of that second C-terminal region
by using a representative synthetic sequence, HIVc, and
electrically neutral LUV as targets. Previous work by our group
(28, 29) has shown that the partition of a sequence
representing the fusion peptide at the N terminus of HIV-1 gp41
(HIVn) has the capacity to destabilize neutral liposomes composed of DOPC, DOPE, and CHOL (molar ratio, 1:1:1). These vesicles select for an extended peptide structure that becomes fusogenic in a
dose-dependent fashion. Morphological data reveal the formation of
nonlamellar lipidic aggregates during the time course of lipid mixing
(30). At subfusogenic doses the fusion peptide also causes the release of trapped contents from liposomes, indicating the existence of a peptide-mediated permeabilization process prior to and
independent from the development of fusion (28, 29). For
comparative purposes we explored the ability of HIVc and
HIVn to perturb DOPC-DOPE-CHOL membranes. Assuming that
both sequences would be present at an equimolar ratio within a
potential fusogenic complex during gp41-mediated fusion, we also
analyzed the membrane-perturbing abilities of a
HIVc-HIVn mixture (1:1 mole ratio).
The HIVc peptide induced membrane fusion in the
DOPC-DOPE-CHOL LUV system employed in this study, as evidenced by the
occurrence of membrane lipid mixing. Figure
2A presents comparative results of
membrane lipid mixing for the three peptide samples, HIVc, HIVn, and HIVc-HIVn, as monitored
with the RET assay. The final extents of fusion were dependent on the
peptide-to-lipid ratios in the three cases. However, data displayed in
Fig. 2 readily demonstrate that, in terms of peptide added per lipid,
the HIVc sequence was more efficient at inducing lipid
mixing than HIVn. For HIVc we consistently
found that the peptide-to-lipid ratio required to induce 20 to 30%
lipid mixing was 1:1,000. In comparison, HIVn induced 10%
lipid mixing at a 10-times-higher peptide-to-lipid ratio of 1:100. The
mixture HIVc-HIVn did not achieve better
results than HIVc by itself. These data strongly support
the idea of HIVc being capable of destabilizing membranes
and inducing them to merge. Moreover, they suggest that this sequence
is a more potent perturbing agent than HIVn.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 2.
Final extents of fusion (A) and leakage (B) as a
function of increasing concentrations of HIVc ( ),
HIVn ( ), and HIVc-HIVn ( ).
The peptide was added to DOPC-DOPE-CHOL LUV at different
peptide-to-lipid ratios (Ri) and incubated for 1 h at 37°C
before measuring the extents of lipid mixing and leakage. Lipid
concentration, 100 µM.
|
|
Analogous results were obtained when the three peptide preparations
were assayed for their ability to release the ANTS-DPX probes from the
aqueous interiors of the DOPC-DOPE-CHOL vesicles (Fig. 2B).
Peptide-induced leakage was activated in all cases at peptide-to-lipid
ratios lower than those that activated lipid mixing. In addition,
HIVc was again more potent than HIVn at lower peptide-to-lipid ratios. At a peptide-to-lipid ratio of 1:5,000 the
extent of leakage induced by HIVc consistently amounted to more than 30%, whereas, to obtain a comparable extent of fusion, the
ratio had to be increased 10-fold. HIVn induced 10%
leakage at a peptide-to-lipid ratio of 1:1,000, whereas a ratio of
1:100 was necessary to detect a comparable amount of lipid mixing. The mixture HIVc-HIVn paralleled the behavior of
HIVc alone.
Taken together, results in Fig. 2 would be consistent with the
existence of membrane perturbations caused by HIVc
partitioning into DOPC-DOPE-CHOL vesicles that are qualitatively
similar to those caused by HIVn partitioning. However,
compared to HIVn, 10-times-less HIVc was
necessary to promote comparable lipid mixing or leakage. This fact may
reflect an inherently higher potency to perturb membranes for the
HIVc sequence or else more peptide associated with vesicles
in HIVc-treated samples. To clarify this issue, the peptide
binding to vesicles was investigated next.
In Fig. 3 we show the fluorescence
spectra obtained utilizing HIVc and the fluorescent F8W
analog of HIVn. At a peptide-to-lipid ratio of 1:100 levels
of intrinsic fluorescence emission in HIVc and in
HIVn changed significantly in the presence of
DOPC-DOPE-CHOL LUV. Emission intensity was enhanced, and the maxima
shifted to lower wavelengths: from 346 to 342 nm for HIVc
and from 354 to 347 nm for HIVn. Both effects suggest that
Trp residues in the presence of vesicles sense a less polar environment
which is indicative of partition and the subsequent penetration of both
peptides into the bilayer millieu. We observed that the levels of Trp
fluorescence of both peptides in solution decreased with time, an
effect that may be related to self-aggregation due to their hydrophobic
character. This process may compete with membrane association and,
therefore, precludes correct determination of real partition
coefficients (41). With this caveat in mind, and just for
comparative purposes, we determined apparent mole fraction partition
coefficients (Kapp) for HIVc and
HIVn (F8W analog). For a peptide-to-lipid ratio of 1:500,
we obtained under our experimental conditions (see Materials and
Methods) 93% of HIVc coeluting with vesicles whereas that value was reduced to 35% for HIVn. Therefore the
Kapp values were 7.3 × 105 for
HIVc and 3.0 × 104 for HIVn.
Again, these values should not be taken as quantitatively reflecting
the energetics of the peptide-membrane interaction process, but rather
as descriptive of the ability of these peptides to associate with
membranes under our particular experimental conditions. They further
indicate that, after correcting for the difference in bound peptide,
membrane-associated HIVn is as effective as
HIVc at perturbing membranes (Fig. 2). Thus, in our in
vitro assays, the activity displayed by HIVn is actually
limited by the ability of the peptide to partition into vesicles, but
this activity in the membrane-bound form would be comparable to that of
HIVc.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 3.
Fluorescence emission spectra of HIVc and
HIVn (F8W analog) in buffer (dotted lines) and incubated
with DOPC-DOPE-CHOL LUV (solid lines). The peptide concentration was 1 µM, and, in vesicle samples, the peptide-to-lipid ratio was 1:100.
au, arbitrary units.
|
|
The extents of fusion and leakage seem to indicate that the mixture
HIVc-HIVn followed a membrane-perturbing
pattern similar to that exhibited by HIVc alone. However
those measurements were carried out after 1 h of incubation of
peptides and vesicles. It is possible that the initial rates of
membrane perturbation might be altered by the combination of both
peptides. Thus, in search for a possible synergism in the mode of
action of HIVc and HIVn, we carried out a
kinetic characterization of the initial stages of the perturbing
processes induced by each of the peptides and by the
HIVc-HIVn mixture. Initial rates of
HIVc-induced lipid mixing increased with peptide
concentration (Fig. 4). We investigated the effect of coadding HIVn on the former process under
conditions where this peptide alone did not induce lipid mixing or
induced it just marginally (i.e., at peptide-to-lipid ratios ranging
from 1:1,000 to 1:100). As shown in Fig. 4, the initial rates of lipid mixing induced by the mixture HIVc-HIVn were
always higher than those induced by HIVc alone. At a ratio
at which HIVn induced extensive lipid mixing by itself,
i.e., 1:25, no additive effects of the
HIVc-HIVn mixture were found. This indicates
that, under most circumstances, synergism between these peptides in the
mode of inducing fusion may occur. Similar results were obtained for the leakage assay, and again potentiation of peptide effects was more
evident at lower peptide-to-lipid ratios (Fig.
5).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 4.
Kinetics of membrane lipid mixing of LUV of
DOPC-DOPE-CHOL (1:1:1) induced by HIVc ( ),
HIVn ( ), and HIVc-HIVn ( ).
The peptide was added at the peptide-to-lipid ratios indicated. Lipid
concentration was 100 µM in all cases.
|
|

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 5.
Kinetics of leakage of ANTS-DPX from LUV of
DOPC-DOPE-CHOL (1:1:1) induced by HIVc ( ),
HIVn ( ), and HIVc-HIVn ( ).
Conditions otherwise were as described for Fig. 4.
|
|
The existence of HIVc-HIVn interactions
underlying their mutual synergism was confirmed by detecting changes of
HIVc Trp fluorescence in the presence of the nonfluorescent
HIVn. The data displayed in Fig.
6 reflect an increase in the emitted
fluorescence intensity of HIVc in solution and a shift of
the wavelength of maximum emission (
max) from 346 to 340 nm when HIVc was premixed with HIVn at a 1:10
HIVc-to-HIVn mole ratio. Results in this figure
further indicate that the Trp emission of HIVc premixed
with HIVn (curve 4) also increased and was slightly blue
shifted from 342 to 338 nm when associated with vesicles. This effect
was clearly larger than the one detected for the fluorescent
HIVc alone (curve 3). According to the estimated partition
coefficients, under the experimental conditions in Fig. 6,
60% of
HIVc was bound to vesicles. Thus, the polarity change
caused by premixing with HIVn might be due to an increase
in binding or might originate from a different bilayer localization of
HIVc when interacting together with HIVn and/or
from the formation of HIVc-HIVn complexes
within the vesicle membranes.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 6.
Trp fluorescence emission spectra of HIVc
alone (0.2 µM) and premixed with HIVn
(HIVc-to-HIVn ratio, 1:10) in buffer and
incubated with DOPC-DOPE-CHOL LUV (HIVc-to-lipid ratio,
1:500). Curves: 1, HIVc in buffer; 2, HIVc-HIVn in buffer; 3, HIVc in the
presence of vesicles; 4, HIVc-HIVn in the
presence of vesicles. au, arbitrary units.
|
|
In order to confirm the relevance of the previous observations, we also
explored the effect of a sequence substitution on the ability of
HIVc to perturb membranes and associate with
HIVn (Fig. 7). The
HIVW(1-3)A sequence with the first three Trp residues of
HIVc replaced by Ala represents the pretransmembrane region
of a mutant gp41 described by Salzwedel et al. (34) as reproducing the phenotype of deleting the sequence spanning residues 665 to 682. This phenotype consists of the specific abolition of
cell-cell fusion and virus entry mediated by gp41 without affecting normal maturation and transport to the cell surface or CD4-binding ability of the envelope glycoprotein. Our results in Fig. 7A show that,
in contrast to HIVc, the HIVW(1-3)A peptide
was unable to induce membrane fusion at peptide-to-lipid molar ratios
ranging from 1:1,000 to 1:100. Since the absence of an effect might be caused by the existence of defective binding, we also measured the
partitioning of this sequence into vesicles. At a 1 mM lipid concentration approximately 50% of the added HIVW(1-3)A peptide partitioned into DOPC-DOPE-CHOL membranes yielding a
Kapp of
55,000. This means that for the
fusion experiments in Fig. 7A the 1:100 HIVW(1-3)A/lipid
ratio condition is comparable to that of the 1:500
HIVc/lipid ratio. We conclude that HIVW(1-3)A bound to membranes was unable to induce the type of perturbations induced by the HIVc parental sequence.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 7.
(A) Kinetics of membrane lipid mixing of LUV of
DOPC-DOPE-CHOL (1:1:1) induced by HIVc ( ) and
HIVW(1-3)A ( ). The peptides were added at the
peptide-to-lipid ratios of 1:500 (HIVc) and 1:100
[HIVW(1-3)A]. Lipid concentration was 100 µM. (B) Trp
fluorescence emission spectra of HIVW(1-3)A (1 µM) in
buffer (dotted line) and incubated with DOPC-DOPE-CHOL LUV
[HIVW(1-3)A-to-lipid ratio, 1:100] (solid lines). au,
arbitrary units.
|
|
The ability of HIVW(1-3)A to associate with membranes may
also be inferred from the emission spectra displayed in Fig. 7B. As for
HIVc and HIVn (Fig. 3) the intrinsic
fluorescence of HIVW(1-3)A increased in the presence of
vesicles, indicating that Trp residues must be sensing a less polar
environment. In contrast to the observed effects for HIVc
(Fig. 6), under comparable conditions the emission of
HIVW(1-3)A did not experience any change in the presence
of the nonfluorescent HIVn (data not shown). The latter
result seems to reflect the absence of
HIVW(1-3)A-HIVn interactions.
The existence of a membrane interface-residing sequence preceding the
transmembrane anchor might represent a particular characteristic of
primate lentiviruses or else a structural motif shared by other retroviruses and other families. To explore this hypothesis, we first
performed on several viral sequences a hydropathy analysis analogous to
those described in Table 1 for primate lentiviruses. The selected
fusogenic sequences (or close homologous relatives) have been either
predicted or formally demonstrated to form hairpin structures. Data in
Table 2 indicate that, with the single
exception of Sendai virus F protein, there exists within the analyzed
sequences a hydrophobic-at-interface region preceding the transmembrane segment. Paramyxovirus-mediated membrane fusion does not require the
sequences connecting the coiled coil and the transmembrane anchor and
might take place according to a mechanism distinct from that proposed
for the rest of the virus families analyzed (1) (see
Discussion). As a control, a similar hydropathy analysis of
transmembrane regions of several human type I membrane proteins (Table
3) revealed that segregation of the
hydrophobic-at-interface domain from the transmembrane segment is not
found in those proteins. The preferential occurrence of aromatic
residues at the cytoplasmic boundary of transmembrane segments in the
human proteins (22, 32) does not account for the position
and length of the interfacially hydrophobic sequences detected in viral
envelope proteins.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Positions and lengths of C-terminal hydrophobic regions
at ectodomains of precursors of envelope fusogenic subunits of
different viruses as detected by
hydropathy analysisa
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Positions and lengths of transmembrane hydrophobic
regions of several human type I membrane proteins as detected by
hydropathy analysisa
|
|
Elongation of sequences containing aromatic residues at the N termini
of membrane-spanning regions is common in viral envelope proteins
implicated in viral fusion. Figure 8
shows sequences from six virus families aligned with respect to the
membrane-spanning hydrophobic region rich in aliphatic amino acids. The
Retroviridae have been further subdivided into their
principal subfamilies, Lentivirinae, types B, C, and D,
avian Oncovirinae, and Spumaretrovirinae. A high
degree of clustering of aromatic amino acids, most prominently tryptophan, is found in the primate and ovine lentiviruses, mammalian oncoviruses of groups B, C, and D, the filoviruses Ebola virus and
Marburg virus, the rhabdovirus vesicular stomatitis virus G protein,
and the alphavirus Sindbis virus E1 protein. A lower level of clustered
aromatics, but higher than expected for type I glycoproteins, is found
in avian retroviruses, spumaretroviruses, influenza A virus HA2, and
the hepatitis C flavivirus E2 protein. Such an unusual concentration of
aromatic amino acids exists against a background of considerable
sequence diversity and in different positions in the linear sequence,
even among closely related viruses. There are notable exceptions to the
pattern, however. As noted in Table 2, the frequency of preinsertion
aromatic amino acids in Sendai paramyxovirus F glycoprotein does not
exceed that expected for type I glycoproteins. Likewise,
Arenavirus GP2 (not shown) lacks any clustering of aromatics.
Therefore, while aromatic and especially tryptophan-rich regions prior
to membrane insertion have membrane-distorting properties that could be
involved in fusion by many viruses, such regions would not appear to be
indispensable.

View larger version (51K):
[in this window]
[in a new window]
|
FIG. 8.
Clustering of aromatic amino acids amino-terminal to the
membrane-spanning region of the transmembrane (TM) superfamily of
glycoproteins. Sequences of TM glycoproteins implicated in fusion are
hand aligned by their membrane-spanning regions, using the
20-amino-acid span of hydrophobicity indicated at the top and bottom by
vertical lines and any apparently conserved amino acids wherever
possible, without introducing any gaps. Selected sequences and GenBank
accession numbers of TM superfamily glycoproteins are as described in
Tables 1 and 2 with the following additional sequences: SA-OMVV, ovine
lentivirus, M13646; EIAV, equine infectious anemia virus, M16575; MMTV,
mouse mammary tumor virus, M15122; BLV, bovine leukemia virus, K02120;
HumFoamy, human foamy spumaretrovirus, U21247; Marburg filovirus GP2,
U31033; VSV, vesicular stomatitis virus, Indiana strain, G protein,
J02428; Sindbis virus E2 protein, J02363; HepC, hepatitis C virus,
strain 1b, flavivirus E2 protein, AJ238800; MPMV, Mason-Pfizer monkey
virus coat protein GP20, M12349.
|
|
 |
DISCUSSION |
Viral fusion proteins are designed to interact simultaneously with
two membranes during the fusion reaction cycle. Interaction with the
virion membrane is primarily mediated by the transmembrane anchor. In
addition protruding ectodomains contain a conserved hydrophobic stretch
of amino acids, the fusion peptide, which is thought to insert into the
target membrane upon fusion activation (4, 13, 14, 17, 19, 33,
40). By using a hydropathy analysis based on the
hydrophobicity-at-interface scale recently proposed by Wimley and White
(45), we have confirmed the high propensity of the gp41
fusion peptide to partition into membranes (Fig. 1). According to our
results (Table 1), within the HIV-1 fusion peptide region, the sequence
IGALFLGFLGAAG containing the conserved FLG motif (13), shows
a high probability to localize at the bilayer interface. Despite the
experimental limitations inherent to the hydrophobicity-at-interface
scale (45), the Wimley-White hydropathy analysis appears to
be clearly superior to others for detecting potential
membrane-interacting sequences within overall soluble polypeptide
domains (42). The most important advantage in comparison
with bulk phase scales is that the Wimley-White scale takes into
account the effect of the membrane interface on partitioning. This
bilayer region consists of a complex mixture of water and chemically
heterogeneous phospholipid groups (polar head groups, glyceryl,
phosphoryl, carbonyl, and methylenes) in which significant changes in
polarity occur at short range (42). This results in the main
difference between the Wimley-White scale and scales such as the one
proposed by Kyte and Doolittle (21): even in the absence of
solid physical foundations (46), aromatic residues, namely,
Phe, Tyr, and Trp, appear to be the most hydrophobic ones when located
at interfaces.
An illustrative example of the differences between scales can be
observed for the C-terminal region within the gp41 ectodomain (Fig. 1).
The Wimley-White hydrophobicity-at-interface scale identifies the
region preceding the gp41 transmembrane anchor as having a high
tendency to partition into the membrane interface. Its pronounced hydrophobic-at-interface character is based on the presence of 1 Phe
residue, 1 Tyr residue, and 5 Trp residues closely located within a
20-residue spanning sequence. The preference of Trp and Tyr residues
for boundary regions that flank the transmembrane domains is a known
feature shared by virtually all known membrane proteins (22,
32). The C-terminal region detected within the gp41 ectodomain
appears to be an elongation tail of membrane surface-residing domains.
To test the functional significance that such a membrane interface-residing domain could have for gp41-mediated HIV-1 fusion, we
characterized it as a membrane-interacting sequence. During the course
of our studies, Salzwedel et al. (34) reported on the effect
of mutations targeted to the same tryptophan-rich domain. More
recently, Muñoz-Barroso et al. (25) have evaluated the effect of those mutations on the various stages of fusion. The mutational and functional analyses have confirmed its crucial role
during gp41-mediated fusion.
Proposed molecular models for viral fusion processes highlight a role
for coiled-coil structures, which were first observed for influenza
virus HA2 (44) and which have been extended to the
retroviruses (15) and filoviruses (14). Formation
of those stable structures could be energetically coupled to membrane
apposition (4, 39). It is generally accepted that both
anchoring and apposition of the viral and target membranes are mediated
by the ectodomains at the transmembrane subunits of envelope proteins such as the HIV-1 gp41. Following gp41-induced apposition, a membrane perturbation is likely to take place within the points of fusion, causing both membranes to merge (4, 39). Within this
framework, the fusion peptide is postulated to anchor the fusion
protein to the target membrane and perturb subsequently apposed
membranes. Our data indicate that the HIV-1 fusion peptide would be
capable of both functions, given its tendency to partition into
membrane interfaces and to perturb their architecture (29,
30). In addition, our experimental data demonstrate that the
sequence preceding the gp41 transmembrane anchor could be implicated in perturbing the apposed membranes as well. According to the leakage, lipid mixing, and binding assays, this sequence was even more potent at
inducing membrane destabilization than the fusion peptide. The
physiological relevance of our in vitro approach was supported by the
fact that a mutation known to block gp41 activity in vivo completely
impaired the ability of HIVc to perturb membranes (Fig. 7).
Similarly, the in vitro membrane activity of the synthetic N-terminal
fusion peptide has been also reported to be sensitive to sequence
substitutions affecting gp41-mediated cell-cell fusion and viral
infectivity (20, 29). Within the hairpin structure postulated to represent the fusion-competent version of gp41, both
sequences would be closely located at the same end of the molecule.
Moreover, if a higher-order envelope glycoprotein complex is involved
in HIV-1 fusion, membrane perturbations induced by both sequences might
be confined to the point of fusion (25, 26).
The presence of two membrane-partitioning sequences separated by a
collapsible intervening sequence is a common motif shared by other
viral envelope products. Results summarized in Table 2 demonstrate
that, with the single exception of those of paramyxoviruses, known
hairpin structures would locate two membrane interface-partitioning sequences in close proximity. Baker et al. (1) demonstrated that paramyxovirus-mediated membrane fusion does not require the flexible sequence connecting the coiled coil and the transmembrane anchor. These authors suggested that conformational changes in paramyxovirus F proteins may involve flexibility in other regions of
the protein such as the intervening sequences connecting the N- and
C-terminal heptad repeats. Thus, in contrast to what is found for the
rest of the analyzed cases, flexibility between membrane-anchoring
regions of the F protein would not suffice to allow hairpin formation.
Influenza virus hemagglutinin also appears to be unique in the sense
that although hydrophobic-at-interface and hydrophobic peaks are
located at different positions, both regions span almost the same
sequence of approximately 25 to 27 residues, i.e., they are not
segregated. Clearly, in order to find a common mechanistic role for
these membrane interface-seeking regions during fusion, more mutational
and functional studies will be necessary. We believe that the new
Wimley-White hydropathy scale will be a powerful predictive tool that
will lead to the detection of functional domains implicated in
protein-membrane interactions during viral fusion events.
The existence of the hydrophobic-at-interface region preceding the
transmembrane anchor appears to be a specific attribute of certain
viral fusion glycoproteins rather than a general feature of type I
membrane proteins (Table 3). In viral proteins, such a region appears
to be an elongation of the short sequences containing aromatic residues
at the cytoplasmic boundary of transmembrane anchors (22,
32). A survey of such regions in a number of virus families
indicates that they are common and especially prominent in the
retrovirus and filovirus families (Fig. 8). While it is difficult to
accurately align highly divergent sequences, the aromatic amino acids
do not occur with any reproducible periodicity, as one would expect in
the
-helical configuration suggested by Salzwedel et al.
(34), even in closely related viruses. Any mechanism by
which these regions participate in fusion must account for the
positional variability.
An alternative explanation for the clustering of tryptophans in
retroviruses relates to the genetic code, in that only the triplet UGG
codes for tryptophan. Any G-to-A hypermutation by reverse transcriptase
at any of five clustered UGG codons could generate a nonsense codon and
premature stop in translation just prior to membrane insertion. This
could generate a population of truncated glycoproteins accumulating
during chronic infections, along with other defective mutants, as
soluble glycoproteins that might function as cellular and immunological
decoys, as does sGP in filoviruses. However, this explanation would not
apply to those viruses such as murine leukemia virus preferentially
rich in phenylalanine. The more likely general explanation for such
preinsertion aromatic clusters is that they promote fusion through
their membrane-distorting properties.
Taken together, these observations point to the possibility that a
number of viral fusogenic subunits might operate by putting into close
contact within the fusion locus two perturbed membranes, that of the
virus and that of the target cell, and/or two interacting perturbing
sequences, the fusion peptide and the surface-residing tail that
precedes the transmembrane anchor.
 |
ACKNOWLEDGMENTS |
We are grateful to Maier Lorizate for technical assistance.
T.S. and A.A. are recipients of predoctoral fellowships from the Basque
Government. This work was supported by DGCYT (grant PB96-0171), the
Basque Government (PI 96-46; EX-1998-28; PI-1998-32), and the
University of the Basque Country (UPV 042.310-EA085/97; UPV
042.310-G03/98). Support to W.R.G. includes senior fellowship 1F32AI08549 and grant 1R01DE10862 from the National Institutes of
Health of the United States.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Unidad de
Biofísica (CSIC-UPV/EHU) y Departamento de Bioquímica,
Universidad del País Vasco, Aptdo. 644, 48080 Bilbao, Spain.
Phone: 34 94 6012615. Fax: 34 94 4648500. E-mail:
GBPNIESJ{at}lg.ehu.es.
 |
REFERENCES |
| 1.
|
Baker, K. A.,
R. E. Dutch,
R. A. Lamb, and T. S. Jardetzky.
1999.
Structural basis for paramyxovirus-mediated membrane fusion.
Mol. Cell
3:309-319[CrossRef][Medline].
|
| 2.
|
Bosch, M. L.,
P. L. Earl,
K. Fargnoli,
S. Picciafuoco,
F. Giombini,
F. Wong-Staal, and G. Franchini.
1989.
Identification of the fusion peptide of primate immunodeficiency viruses.
Science
244:694-697[Abstract/Free Full Text].
|
| 3.
|
Böttcher, C. S. F.,
C. M. van Gent, and C. Fries.
1961.
A rapid and sensitive sub-micro phosphorus determination.
Anal. Chim. Acta
24:203-204[CrossRef].
|
| 4.
|
Chan, D. C., and P. S. Kim.
1998.
HIV entry and its inhibition.
Cell
93:681-684[CrossRef][Medline].
|
| 5.
|
Chan, D. C.,
D. Fass,
J. M. Berger, and P. S. Kim.
1997.
Core structure of gp41 from the HIV-1 envelope glycoprotein.
Cell
89:263-273[CrossRef][Medline].
|
| 6.
|
Colotto, A., and R. M. Epand.
1997.
Structural study of the relationship between the rate of membrane fusion and the ability of the fusion peptide of influenza virus to perturb bilayers.
Biochemistry
36:7644-7651[CrossRef][Medline].
|
| 7.
|
Dalgleish, A. G.,
P. C. L. Beverley, and P. R. Clapham.
1984.
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.
Nature
312:763-767[CrossRef][Medline].
|
| 8.
|
Doms, R. W., and S. C. Peiper.
1997.
Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry.
Virology
235:179-190[CrossRef][Medline].
|
| 8a.
|
Eckert, D. M.,
V. N. Malashkevich,
L. H. Hong,
P. A. Carr, and P. S. Kim.
1999.
Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket.
Cell
99:103-115[CrossRef][Medline].
|
| 9.
|
Ellens, H.,
J. Bentz, and F. C. Szoka.
1985.
H+- and Ca2+-induced fusion and destabilization of liposomes.
Biochemistry
24:3099-3106[CrossRef][Medline].
|
| 9a.
|
Ferrer, M.,
T. M. Kapoor,
T. Strassmaier,
W. Weissenhorn,
J. J. Skehel,
D. Oparian,
S. L. Schreiber,
D. C. Wiley, and S. C. Harrison.
1999.
Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements.
Nat. Struct. Biol.
6:953-960[CrossRef][Medline].
|
| 10.
|
Freed, E. O.,
D. J. Myers, and R. Risser.
1990.
Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41.
Proc. Natl. Acad. Sci. USA
87:4650-4654[Abstract/Free Full Text].
|
| 11.
|
Freed, E. O.,
E. L. Delwart,
G. L. Buchschacher, and A. T. Panganiban.
1992.
A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity.
Proc. Natl. Acad. Sci. USA
89:70-74[Abstract/Free Full Text].
|
| 12.
|
Furuta, R. A.,
C. T. Wild,
Y. Weng, and C. D. Weiss.
1998.
Capture of an early fusion-active conformation of HIV-1 gp41.
Nat. Struct. Biol.
5:276-279[CrossRef][Medline].
|
| 13.
|
Gallaher, W. R.
1987.
Detection of a fusion peptide sequence in the transmembrane protein of the human immunodeficiency virus.
Cell
50:327-328[CrossRef][Medline].
|
| 14.
|
Gallaher, W. R.
1996.
Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses.
Cell
85:477-478[CrossRef][Medline].
|
| 15.
|
Gallaher, W. R.,
J. M. Ball,
R. F. Garry,
M. C. Griffin, and R. C. Montelaro.
1989.
A general model for the transmembrane proteins of HIV and other retroviruses.
AIDS Res. Hum. Retroviruses
5:431-440[Medline].
|
| 16.
|
Gordon, L. M.,
C. C. Curtain,
Y. C. Zhong,
A. Kirkpatrick,
P. W. Mobley, and A. J. Waring.
1992.
The amino terminal peptide of HIV-1 glycoprotein 41 interacts with human erythrocyte membranes: peptide conformation, orientation and aggregation.
Biochim. Biophys. Acta
1139:257-274[Medline].
|
| 17.
|
Hernández, L. D.,
L. R. Hoffman,
T. G. Wolfsberg, and J. M. White.
1996.
Virus-cell and cell-cell fusion.
Annu. Rev. Cell Dev. Biol.
12:627-661[CrossRef][Medline].
|
| 18.
|
Hope, M. J.,
M. B. Bally,
G. Webb, and P. R. Cullis.
1985.
Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential.
Biochim. Biophys. Acta
812:55-65[CrossRef].
|
| 19.
|
Hughson, F. M.
1997.
Enveloped viruses: a common mode of membrane fusion?
Curr. Biol.
7:565-569.
|
| 19a.
|
Kilby, J. M.,
S. Hopkins,
T. M. Venetta, et al.
1998.
Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry.
Nat. Med.
4:1302-1307[CrossRef][Medline].
|
| 20.
|
Kliger, Y.,
A. Aharon,
D. Rapaport,
P. Jones,
R. Blumenthal, and Y. Shai.
1997.
Fusion peptides derived from the HIV type I glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell fusion.
J. Biol. Chem.
272:13496-13505[Abstract/Free Full Text].
|
| 21.
|
Kyte, J., and R. F. Doolittle.
1982.
A simple method for displaying the hydropathic character of a protein.
J. Mol. Biol.
157:105-132[CrossRef][Medline].
|
| 22.
|
Landolt-Marticorena, C.,
K. A. Williams,
C. M. Deber, and R. A. F. Reithmeier.
1993.
Non-random distribution of amino acids in the transmembrane segments of human type I single span membrane proteins.
J. Mol. Biol.
229:602-608[CrossRef][Medline].
|
| 23.
|
Martin, I.,
F. Defrise-Quertain,
E. Decroly,
M. Vandenbranden,
R. Brasseur, and J. M. Ruysschaert.
1993.
Orientation and structure of the NH2-terminal HIV-1 gp41 peptide in fused and aggregated liposomes.
Biochim. Biophys. Acta.
1145:124-133[Medline].
|
| 24.
|
Moore, J. P.,
A. J. Bradford,
R. Weiss, and Q. J. Sattentau.
1993.
The HIV-cell fusion reaction, p. 233-289.
In
J. Bentz (ed.), Viral fusion mechanisms. CRC Press Inc., Boca Raton, Fla.
|
| 25.
|
Muñoz-Barroso, I.,
S. Durell,
K. Sakaguchi,
E. Appella, and R. Blumenthal.
1998.
Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41.
J. Cell Biol.
140:315-323[Abstract/Free Full Text].
|
| 26.
|
Muñoz-Barroso, I.,
K. Salzwedel,
E. Hunter, and R. Blumenthal.
1999.
Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion.
J. Virol.
73:6089-6092[Abstract/Free Full Text].
|
| 27.
|
Nieva, J. L.,
S. Nir,
A. Muga,
F. M. Goñi, and J. Wilschut.
1994.
Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for leakage and fusion.
Biochemistry
33:3201-3209[CrossRef][Medline].
|
| 28.
|
Nieva, J. L.,
S. Nir, and J. Wilschut.
1998.
Destabilization and fusion of zwitterionic large unilamellar lipid vesicles induced by a -type structure of the HIV-1 fusion peptide.
J. Liposome Res.
8:165-182.
|
| 29.
|
Pereira, F. B.,
F. M. Goñi,
A. Muga, and J. L. Nieva.
1997.
Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects.
Biophys. J.
73:1977-1986[Medline].
|
| 30.
|
Pereira, F. B.,
J. M. Valpuesta,
G. Basañez,
F. M. Goñi, and J. L. Nieva.
1999.
Interbilayer lipid-mixing induced by the HIV-1 fusion peptide on large unilamellar vesicles: the nature of the nonlamellar intermediates.
Chem. Phys. Lipids
103:11-20[CrossRef][Medline].
|
| 31.
|
Rafalski, M.,
J. Lear, and W. DeGrado.
1990.
Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41.
Biochemistry
29:7917-7922[CrossRef][Medline].
|
| 32.
|
Reithmeier, R. A. F.
1995.
Characterization and modeling of membrane protein using sequence analysis.
Curr. Opin. Struct. Biol.
5:491-500[CrossRef][Medline].
|
| 33.
|
Ruiz-Argüello, M. B.,
F. M. Goñi,
F. B. Pereira, and J. L. Nieva.
1998.
Phosphatidylinositol-dependent membrane fusion induced by a putative fusogenic sequence of Ebola virus.
J. Virol.
72:1775-1781[Abstract/Free Full Text].
|
| 34.
|
Salzwedel, K.,
J. T. West, and E. Hunter.
1999.
A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity.
J. Virol.
73:2469-2480[Abstract/Free Full Text].
|
| 35.
|
Schaal, H.,
M. Klein,
P. Gehrmann,
O. Adams, and A. Scheid.
1995.
Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion.
J. Virol.
69:3308-3314[Abstract].
|
| 36.
|
Slepushkin, V. A.,
S. M. Andreev,
M. V. Sidorova,
G. B. Melikyan,
V. B. Grigoriev,
V. M. Chumakov,
A. E. Grinfeldt,
R. A. Manukyan, and E. V. Karamov.
1992.
Investigation of human immunodeficiency virus fusion peptides. Analysis of interrelations between their structure and function.
AIDS Res. Hum. Retroviruses
8:9-18[Medline].
|
| 37.
|
Struck, D. K.,
D. Hoekstra, and R. E. Pagano.
1981.
Use of resonance energy transfer to monitor membrane fusion.
Biochemistry
20:4093-4099[CrossRef][Medline].
|
| 38.
|
Turner, B. G., and M. F. Summers.
1999.
Structural biology of HIV.
J. Mol. Biol.
285:1-32[CrossRef][Medline].
|
| 39.
|
Weissenhorn, W.,
A. Dessen,
S. C. Harrison,
J. J. Skehel, and D. C. Wiley.
1997.
Atomic structure of the ectodomain from HIV-1 gp41.
Nature
387:426-428[CrossRef][Medline].
|
| 40.
|
White, J.
1992.
Membrane fusion.
Science
258:917-923[Abstract/Free Full Text].
|
| 41.
|
White, S.,
W. C. Wimley,
A. S. Ladokhin, and K. Hristova.
1998.
Protein folding in membranes: determining energetics of peptide-bilayer interactions.
Methods Enzymol.
295:62-87[CrossRef][Medline].
|
| 42.
|
White, S. H., and W. C. Wimley.
1999.
Membrane protein folding and stability: physical principles.
Annu. Rev. Biophys. Biomol. Struct.
28:319-365[CrossRef][Medline].
|
| 43.
|
Wild, C.,
D. C. Shugars,
T. Greenwell,
C. McDanal, and T. Matthews.
1994.
Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type-1 gp41 are potent inhibitors of virus infection.
Proc. Natl. Acad. Sci. USA
91:9770-9774[Abstract/Free Full Text].
|
| 44.
|
Wilson, I. A.,
J. J. Skehel, and D. C. Wiley.
1981.
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution.
Nature
289:366-373[CrossRef][Medline].
|
| 45.
|
Wimley, W., and S. H. White.
1996.
Experimentally determined hydrophobicity scale for proteins at membrane interfaces.
Nat. Struct. Biol.
3:842-848[CrossRef][Medline].
|
| 46.
|
Yau, W.,
W. C. Wimley,
K. Gawrisch, and S. H. White.
1998.
The preference of tryptophan for membrane interfaces.
Biochemistry
37:14713-14718[CrossRef][Medline].
|
Journal of Virology, September 2000, p. 8038-8047, Vol. 74, No. 17
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Bryson, S., Julien, J.-P., Hynes, R. C., Pai, E. F.
(2009). Crystallographic Definition of the Epitope Promiscuity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5: Vaccine Design Implications. J. Virol.
83: 11862-11875
[Abstract]
[Full Text]
-
Li, Z., Blissard, G. W.
(2009). The Pre-Transmembrane Domain of the Autographa californica Multicapsid Nucleopolyhedrovirus GP64 Protein Is Critical for Membrane Fusion and Virus Infectivity. J. Virol.
83: 10993-11004
[Abstract]
[Full Text]
-
Pejchal, R., Gach, J. S., Brunel, F. M., Cardoso, R. M., Stanfield, R. L., Dawson, P. E., Burton, D. R., Zwick, M. B., Wilson, I. A.
(2009). A Conformational Switch in Human Immunodeficiency Virus gp41 Revealed by the Structures of Overlapping Epitopes Recognized by Neutralizing Antibodies. J. Virol.
83: 8451-8462
[Abstract]
[Full Text]
-
Chen, S. S.-L., Yang, P., Ke, P.-Y., Li, H.-F., Chan, W.-E., Chang, D.-K., Chuang, C.-K., Tsai, Y., Huang, S.-C.
(2009). Identification of the LWYIK Motif Located in the Human Immunodeficiency Virus Type 1 Transmembrane gp41 Protein as a Distinct Determinant for Viral Infection. J. Virol.
83: 870-883
[Abstract]
[Full Text]
-
Huarte, N., Lorizate, M., Maeso, R., Kunert, R., Arranz, R., Valpuesta, J. M., Nieva, J. L.
(2008). The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 4E10 Monoclonal Antibody Is Better Adapted to Membrane-Bound Epitope Recognition and Blocking than 2F5. J. Virol.
82: 8986-8996
[Abstract]
[Full Text]
-
Vishwanathan, S. A., Hunter, E.
(2008). Importance of the Membrane-Perturbing Properties of the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 gp41 to Viral Fusion. J. Virol.
82: 5118-5126
[Abstract]
[Full Text]
-
Howard, M. W., Travanty, E. A., Jeffers, S. A., Smith, M. K., Wennier, S. T., Thackray, L. B., Holmes, K. V.
(2008). Aromatic Amino Acids in the Juxtamembrane Domain of Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Are Important for Receptor-Dependent Virus Entry and Cell-Cell Fusion. J. Virol.
82: 2883-2894
[Abstract]
[Full Text]
-
Montero, M., van Houten, N. E., Wang, X., Scott, J. K.
(2008). The Membrane-Proximal External Region of the Human Immunodeficiency Virus Type 1 Envelope: Dominant Site of Antibody Neutralization and Target for Vaccine Design. Microbiol. Mol. Biol. Rev.
72: 54-84
[Abstract]
[Full Text]
-
Bellamy-McIntyre, A. K., Lay, C.-S., Baar, S., Maerz, A. L., Talbo, G. H., Drummer, H. E., Poumbourios, P.
(2007). Functional Links between the Fusion Peptide-proximal Polar Segment and Membrane-proximal Region of Human Immunodeficiency Virus gp41 in Distinct Phases of Membrane Fusion. J. Biol. Chem.
282: 23104-23116
[Abstract]
[Full Text]
-
Giannecchini, S., D'Ursi, A. M., Esposito, C., Scrima, M., Zabogli, E., Freer, G., Rovero, P., Bendinelli, M.
(2007). Antibodies Generated in Cats by a Lipopeptide Reproducing the Membrane-Proximal External Region of the Feline Immunodeficiency Virus Transmembrane Enhance Virus Infectivity. CVI
14: 944-951
[Abstract]
[Full Text]
-
Lorizate, M., Cruz, A., Huarte, N., Kunert, R., Perez-Gil, J., Nieva, J. L.
(2006). Recognition and Blocking of HIV-1 gp41 Pre-transmembrane Sequence by Monoclonal 4E10 Antibody in a Raft-like Membrane Environment. J. Biol. Chem.
281: 39598-39606
[Abstract]
[Full Text]
-
Wallin, M., Ekstrom, M., Garoff, H.
(2006). Receptor-Triggered but Alkylation-Arrested Env of Murine Leukemia Virus Reveals the Transmembrane Subunit in a Prehairpin Conformation. J. Virol.
80: 9921-9925
[Abstract]
[Full Text]
-
Gianni, T., Fato, R., Bergamini, C., Lenaz, G., Campadelli-Fiume, G.
(2006). Hydrophobic {alpha}-Helices 1 and 2 of Herpes Simplex Virus gH Interact with Lipids, and Their Mimetic Peptides Enhance Virus Infection and Fusion.. J. Virol.
80: 8190-8198
[Abstract]
[Full Text]
-
Ou, W., Lu, N., Yu, S. S., Silver, J.
(2006). Effect of Epitope Position on Neutralization by Anti-Human Immunodeficiency Virus Monoclonal Antibody 2F5. J. Virol.
80: 2539-2547
[Abstract]
[Full Text]
-
Broer, R., Boson, B., Spaan, W., Cosset, F.-L., Corver, J.
(2006). Important Role for the Transmembrane Domain of Severe Acute Respiratory Syndrome Coronavirus Spike Protein during Entry. J. Virol.
80: 1302-1310
[Abstract]
[Full Text]
-
Galdiero, S., Falanga, A., Vitiello, M., Browne, H., Pedone, C., Galdiero, M.
(2005). Fusogenic Domains in Herpes Simplex Virus Type 1 Glycoprotein H. J. Biol. Chem.
280: 28632-28643
[Abstract]
[Full Text]
-
Sainz, B. Jr., Rausch, J. M., Gallaher, W. R., Garry, R. F., Wimley, W. C.
(2005). Identification and Characterization of the Putative Fusion Peptide of the Severe Acute Respiratory Syndrome-Associated Coronavirus Spike Protein. J. Virol.
79: 7195-7206
[Abstract]
[Full Text]
-
Pascual, R., Moreno, M. R., Villalain, J.
(2005). A Peptide Pertaining to the Loop Segment of Human Immunodeficiency Virus gp41 Binds and Interacts with Model Biomembranes: Implications for the Fusion Mechanism. J. Virol.
79: 5142-5152
[Abstract]
[Full Text]
-
Zwick, M. B., Jensen, R., Church, S., Wang, M., Stiegler, G., Kunert, R., Katinger, H., Burton, D. R.
(2005). Anti-Human Immunodeficiency Virus Type 1 (HIV-1) Antibodies 2F5 and 4E10 Require Surprisingly Few Crucial Residues in the Membrane-Proximal External Region of Glycoprotein gp41 To Neutralize HIV-1. J. Virol.
79: 1252-1261
[Abstract]
[Full Text]
-
von Messling, V., Milosevic, D., Devaux, P., Cattaneo, R.
(2004). Canine Distemper Virus and Measles Virus Fusion Glycoprotein Trimers: Partial Membrane-Proximal Ectodomain Cleavage Enhances Function. J. Virol.
78: 7894-7903
[Abstract]
[Full Text]
-
Shnaper, S., Sackett, K., Gallo, S. A., Blumenthal, R., Shai, Y.
(2004). The C- and the N-terminal Regions of Glycoprotein 41 Ectodomain Fuse Membranes Enriched and Not Enriched with Cholesterol, Respectively. J. Biol. Chem.
279: 18526-18534
[Abstract]
[Full Text]
-
Shmulevitz, M., Epand, R. F., Epand, R. M., Duncan, R.
(2004). Structural and Functional Properties of an Unusual Internal Fusion Peptide in a Nonenveloped Virus Membrane Fusion Protein. J. Virol.
78: 2808-2818
[Abstract]
[Full Text]
-
de Rosny, E., Vassell, R., Jiang, S., Kunert, R., Weiss, C. D.
(2004). Binding of the 2F5 Monoclonal Antibody to Native and Fusion-Intermediate Forms of Human Immunodeficiency Virus Type 1 gp41: Implications for Fusion-Inducing Conformational Changes. J. Virol.
78: 2627-2631
[Abstract]
[Full Text]
-
Jeetendra, E., Ghosh, K., Odell, D., Li, J., Ghosh, H. P., Whitt, M. A.
(2003). The Membrane-Proximal Region of Vesicular Stomatitis Virus Glycoprotein G Ectodomain Is Critical for Fusion and Virus Infectivity. J. Virol.
77: 12807-12818
[Abstract]
[Full Text]
-
Peisajovich, S. G., Gallo, S. A., Blumenthal, R., Shai, Y.
(2003). C-terminal Octylation Rescues an Inactive T20 Mutant: IMPLICATIONS FOR THE MECHANISM OF HIV/SIMIAN IMMUNODEFICIENCY VIRUS-INDUCED MEMBRANE FUSION. J. Biol. Chem.
278: 21012-21017
[Abstract]
[Full Text]
-
Giannecchini, S., Di Fenza, A., D'Ursi, A. M., Matteucci, D., Rovero, P., Bendinelli, M.
(2003). Antiviral Activity and Conformational Features of an Octapeptide Derived from the Membrane-Proximal Ectodomain of the Feline Immunodeficiency Virus Transmembrane Glycoprotein. J. Virol.
77: 3724-3733
[Abstract]
[Full Text]
-
Sanz, M. A., Madan, V., Carrasco, L., Nieva, J. L.
(2003). Interfacial Domains in Sindbis Virus 6K Protein. DETECTION AND FUNCTIONAL CHARACTERIZATION. J. Biol. Chem.
278: 2051-2057
[Abstract]
[Full Text]
-
Joyce, J. G., Hurni, W. M., Bogusky, M. J., Garsky, V. M., Liang, X., Citron, M. P., Danzeisen, R. C., Miller, M. D., Shiver, J. W., Keller, P. M.
(2002). Enhancement of alpha -Helicity in the HIV-1 Inhibitory Peptide DP178 Leads to an Increased Affinity for Human Monoclonal Antibody 2F5 but Does Not Elicit Neutralizing Responses in Vitro. IMPLICATIONS FOR VACCINE DESIGN. J. Biol. Chem.
277: 45811-45820
[Abstract]
[Full Text]
-
Jeetendra, E., Robison, C. S., Albritton, L. M., Whitt, M. A.
(2002). The Membrane-Proximal Domain of Vesicular Stomatitis Virus G Protein Functions as a Membrane Fusion Potentiator and Can Induce Hemifusion. J. Virol.
76: 12300-12311
[Abstract]
[Full Text]
-
Johnston, E. R., Albritton, L. M., Radke, K.
(2002). Envelope Proteins Containing Single Amino Acid Substitutions Support a Structural Model of the Receptor-Binding Domain of Bovine Leukemia Virus Surface Protein. J. Virol.
76: 10861-10872
[Abstract]
[Full Text]
-
Saez-Cirion, A., Nir, S., Lorizate, M., Agirre, A., Cruz, A., Perez-Gil, J., Nieva, J. L.
(2002). Sphingomyelin and Cholesterol Promote HIV-1 gp41 Pretransmembrane Sequence Surface Aggregation and Membrane Restructuring. J. Biol. Chem.
277: 21776-21785
[Abstract]
[Full Text]
-
Zwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M., Moore, J. P., Stiegler, G., Katinger, H., Burton, D. R., Parren, P. W. H. I.
(2001). Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41. J. Virol.
75: 10892-10905
[Abstract]
[Full Text]